Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹59.72
Market cap
₹128.8 Cr
Revenue (annual)
₹23.73 Cr
Net profit (annual)
₹-16.93 Cr
P/E (TTM)
-9.1×Sector 47.3×
Promoter holding
72.74%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10:49 IST BSE
Board Meeting Date

Krebs Biochemicals & Industries Board Meeting Date

Krebs Biochemicals & Industries has scheduled a board meeting for August 6, 2026. The board will consider and adopt the unaudited Q1 results for June 30, 2026.